我大旗网
现在技术越来越先进,特别是对于鉴别图片重复问题,例如这篇2004年发表的一区SCI就是因为图片重复使用问题于2021年3月5日被撤稿了,文章发表在 British Journal of Cancer 上, 该期刊属于nature子刊,也是专业内的老牌期刊 。这篇文章多张图片涉嫌与别的文章重复,由于作者没有办法提供原始数据证明就期刊编辑部撤稿了。 文章题目: Retraction Note to: Id-1 stimulates cell proliferation through activation of EGFR in ovarian cancer cells 官方撤稿理由如下: The Editor-in-Chief has retracted this article because serious concerns have been raised about integrity of the data. Specifically: Figure 1a—the Id-1 and Actin bands for the Skov3 panel appear to be very similar. The Actin bands in the Ovca433 panel in Figure 1a seem very similar to the Actin bands for the Ovca433 panel in Figure 4a. Figure 1a—it appears that some images have been published earlier with different labels by some of the same authors. In Figure 1b the Actin band for the Ovca420 panel and the Actin band for the Ovca432 panel seem to be mirror images[1,2]. The authors were unable to provide raw data. The data reported in this article are therefore unreliable. S.W. Tsao agrees to this retraction. The editor was not able to obtain a current email address for X. Zhang, M.-T. Ling, H. Feng, Y.C. Wong and X. Wang. 参考文章: 1、Ling, M., Wang, X. S., Ouyang, X., Xu, K., Tsao, S. W. & Wong, Y. C. Id-1 expression promotes cell survival through activation of NF-kB signalling pathway in prostate cancer cells. Oncogene 22, 4498–4508, (2003). 2、Cheung, H. W., Ling, M.-t, Tsao, S. W., Wong, Y. C. & Wang, X. Id-1-induced Raf/MEK pathway activation is essential for its protective role against taxol-induced apoptosis in nasopharyngeal carcinoma cells. Carcinogenesis 25, 881–887, (2004). 图片重复使用细节问题: 撤稿官网: 参考链接:
那就要看是通过哪种程序撤的,正规程序就没有问题
有影响,但是论文可以在出版前撤回,如果出版后不能撤回。也许有作者遇到过这样的情况,因为各种原因想在提交后撤回。如果作者想在出版前撤回稿件,好尽快撤回,对作者的影
可以撤稿,不过比较麻烦,需要提供相关资料
《最高人民法院关于审理著作权民事纠纷案件适用法律若干问题的解释》(2002年) 第十九条 出版者、制作者应当对其出版、制作有合法授权承担举证责任,发行者、出
意味着不通过。投递出去的论文,面临的命运不外乎便是接受和拒稿。而好的论文期刊由于对文章质量的要求严格、内容与期刊相关性强等原因会对来稿进行严苛的筛选。这也是造成